$266 Million is the total value of ACUTA CAPITAL PARTNERS, LLC's 67 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 67.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LBIO | Sell | LION BIOTECHNOLOGIES INC | $26,582,000 | +1.5% | 3,229,916 | -0.1% | 9.98% | -20.7% |
| VCYT | Sell | VERACYTE INC | $23,931,000 | +49.3% | 3,144,649 | -1.3% | 8.98% | +16.6% |
| IRIX | Buy | IRIDEX CORP | $17,687,000 | +18.2% | 1,220,611 | +20.6% | 6.64% | -7.7% |
| IMMU | Sell | IMMUNOMEDICS INC | $12,513,000 | +28.4% | 3,850,000 | -8.3% | 4.70% | +0.3% |
| EVDY | Buy | EVERYDAY HEALTH INC | $11,920,000 | +60.1% | 1,550,000 | +64.0% | 4.48% | +25.1% |
| AERI | New | AERIE PHARMACEUTICALS INC | $10,567,000 | – | 280,000 | +100.0% | 3.97% | – |
| XBI | New | SPDR SERIES TRUSTput | $9,944,000 | – | 150,000 | +100.0% | 3.73% | – |
| Sell | NEURODERM LTD | $8,560,000 | -16.9% | 462,956 | -27.0% | 3.21% | -35.1% | |
| EDGE | Buy | EDGE THERAPEUTICS INC | $7,318,000 | +36.6% | 703,000 | +32.6% | 2.75% | +6.7% |
| ASND | Sell | ASCENDIS PHARMA A Ssponsored adr | $7,296,000 | +16.3% | 363,000 | -23.2% | 2.74% | -9.2% |
| ACAD | Buy | ACADIA PHARMACEUTICALS INC | $6,998,000 | +150.6% | 220,000 | +155.8% | 2.63% | +95.8% |
| MRVL | Buy | MARVELL TECHNOLOGY GROUP LTDord | $6,768,000 | +196.5% | 510,000 | +112.9% | 2.54% | +131.6% |
| CASM | Buy | CAS MED SYS INC | $6,647,000 | +3.2% | 3,845,365 | +9.8% | 2.50% | -19.4% |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $6,335,000 | +41.2% | 700,000 | +16.7% | 2.38% | +10.3% |
| Buy | IMMUNOMEDICS INCnote 4.750% 2/1 | $6,333,000 | +69.6% | 7,500,000 | +36.4% | 2.38% | +32.6% | |
| CEMI | Buy | CHEMBIO DIAGNOSTICS INC | $5,710,000 | +5610.0% | 771,676 | +6235.6% | 2.14% | +4366.7% |
| GWPH | New | GW PHARMACEUTICALS PLCads | $5,507,000 | – | 41,487 | +100.0% | 2.07% | – |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $5,122,000 | +36.4% | 407,815 | -2.3% | 1.92% | +6.5% |
| CEMP | CEMPRA INC | $5,082,000 | +46.8% | 210,000 | 0.0% | 1.91% | +14.7% | |
| IWM | Sell | ISHARES TRput | $4,968,000 | -13.6% | 40,000 | -20.0% | 1.86% | -32.5% |
| FOLD | Sell | AMICUS THERAPEUTICS INC | $4,958,000 | -21.8% | 670,000 | -42.3% | 1.86% | -38.9% |
| WBMD | Buy | WEBMD HEALTH CORP | $4,722,000 | +225.0% | 95,000 | +280.0% | 1.77% | +154.0% |
| NBRV | Buy | NABRIVA THERAPEUTICS AGsponsored adr | $4,114,000 | -1.8% | 583,521 | +4.4% | 1.54% | -23.3% |
| VNDA | New | VANDA PHARMACEUTICALS INC | $4,093,000 | – | 245,995 | +100.0% | 1.54% | – |
| INNL | Buy | INNOCOLL HLDGS PLC | $3,902,000 | +24.7% | 671,517 | +18.2% | 1.46% | -2.6% |
| DERM | Sell | DERMIRA INC | $3,619,000 | -27.2% | 107,000 | -37.1% | 1.36% | -43.1% |
| SRPT | Sell | SAREPTA THERAPEUTICS INC | $3,071,000 | +23.9% | 50,000 | -61.5% | 1.15% | -3.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $2,776,000 | -44.2% | 30,000 | -53.1% | 1.04% | -56.5% |
| PGNX | Sell | PROGENICS PHARMACEUTICALS IN | $2,737,000 | +44.5% | 432,370 | -3.7% | 1.03% | +13.0% |
| BCRX | New | BIOCRYST PHARMACEUTICALS | $2,445,000 | – | 554,448 | +100.0% | 0.92% | – |
| SRPT | Sell | SAREPTA THERAPEUTICS INCcall | $2,438,000 | +59.8% | 39,700 | -50.4% | 0.92% | +24.8% |
| TSRO | Sell | TESARO INC | $2,275,000 | -9.8% | 22,700 | -24.3% | 0.85% | -29.5% |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $2,265,000 | +81.1% | 314,211 | +39.4% | 0.85% | +41.4% |
| AERI | New | AERIE PHARMACEUTICALS INCcall | $2,249,000 | – | 59,600 | +100.0% | 0.84% | – |
| RDUS | New | RADIUS HEALTH INC | $2,164,000 | – | 40,000 | +100.0% | 0.81% | – |
| GHDX | Buy | GENOMIC HEALTH INC | $2,085,000 | +65.0% | 72,100 | +47.7% | 0.78% | +29.0% |
| DBVT | New | DBV TECHNOLOGIES S Asponsored adr | $2,044,000 | – | 56,260 | +100.0% | 0.77% | – |
| ALR | New | ALERE INC | $1,946,000 | – | 45,000 | +100.0% | 0.73% | – |
| Buy | ESSA PHARMA INC | $1,678,000 | -4.3% | 586,700 | +2.9% | 0.63% | -25.3% | |
| ALIM | ALIMERA SCIENCES INC | $1,452,000 | +21.2% | 974,318 | 0.0% | 0.54% | -5.4% | |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $1,321,000 | – | 25,000 | +100.0% | 0.50% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $1,272,000 | – | 40,000 | +100.0% | 0.48% | – |
| SVA | Buy | SINOVAC BIOTECH LTD | $1,206,000 | +53.4% | 204,358 | +54.2% | 0.45% | +19.8% |
| ATRC | Sell | ATRICURE INC | $1,047,000 | -34.4% | 66,186 | -41.4% | 0.39% | -48.8% |
| ONS | Buy | ONCOBIOLOGICS INC | $1,043,000 | +26.0% | 245,391 | +0.8% | 0.39% | -1.5% |
| AZN | New | ASTRAZENECA PLCsponsored adr | $986,000 | – | 30,000 | +100.0% | 0.37% | – |
| MRTX | MIRATI THERAPEUTICS INC | $826,000 | +20.9% | 125,000 | 0.0% | 0.31% | -5.5% | |
| AGEN | New | AGENUS INC | $748,000 | – | 104,178 | +100.0% | 0.28% | – |
| THC | New | TENET HEALTHCARE CORP | $743,000 | – | 32,809 | +100.0% | 0.28% | – |
| EHIC | New | EHI CAR SVCS LTDspon ads cl a | $603,000 | – | 58,827 | +100.0% | 0.23% | – |
| CRBP | New | CORBUS PHARMACEUTICALS HLDGS | $552,000 | – | 81,302 | +100.0% | 0.21% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALScall | $473,000 | – | 107,200 | +100.0% | 0.18% | – |
| RIGL | New | RIGEL PHARMACEUTICALS INCcall | $367,000 | – | 100,000 | +100.0% | 0.14% | – |
| TROV | Buy | TROVAGENE INCput | $359,000 | +52.1% | 80,000 | +53.8% | 0.14% | +19.5% |
| ARDX | New | ARDELYX INC | $337,000 | – | 26,076 | +100.0% | 0.13% | – |
| PGNX | New | PROGENICS PHARMACEUTICALS INcall | $253,000 | – | 40,000 | +100.0% | 0.10% | – |
| DXTRQ | DEXTERA SURGICAL INC | $242,000 | +4.3% | 128,958 | 0.0% | 0.09% | -18.0% | |
| BCRX | New | BIOCRYST PHARMACEUTICALSput | $223,000 | – | 50,600 | +100.0% | 0.08% | – |
| AKTX | Sell | AKARI THERAPEUTICS PLCsponsored adr | $197,000 | -55.8% | 23,169 | -30.0% | 0.07% | -65.4% |
| IMMU | IMMUNOMEDICS INCcall | $190,000 | +39.7% | 58,600 | 0.0% | 0.07% | +9.2% | |
| CBMX | COMBIMATRIX CORPORATION | $133,000 | -2.2% | 47,431 | 0.0% | 0.05% | -23.1% | |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $100,000 | – | 10,193 | +100.0% | 0.04% | – |
| ONSIZ | ONCOBIOLOGICS INC*w exp 05/18/201 | $97,000 | +120.5% | 96,833 | 0.0% | 0.04% | +71.4% | |
| MNKD | MANNKIND CORPput | $56,000 | -46.2% | 90,000 | 0.0% | 0.02% | -58.0% | |
| ONSIW | ONCOBIOLOGICS INC*w exp 02/18/201 | $47,000 | +4.4% | 96,833 | 0.0% | 0.02% | -18.2% | |
| RIGL | New | RIGEL PHARMACEUTICALS INCput | $44,000 | – | 11,900 | +100.0% | 0.02% | – |
| PTX | Buy | PERNIX THERAPEUTICS HLDGS INput | $46,000 | +64.3% | 73,500 | +17.0% | 0.02% | +30.8% |
| RLYP | Exit | RELYPSA INCcall | $0 | – | -10,000 | -100.0% | -0.09% | – |
| AUDC | Exit | AUDIOCODES LTDord | $0 | – | -45,035 | -100.0% | -0.09% | – |
| CYTR | Exit | CYTRX CORPput | $0 | – | -100,000 | -100.0% | -0.11% | – |
| CDNA | Exit | CAREDX INC | $0 | – | -64,627 | -100.0% | -0.13% | – |
| BEAT | Exit | BIOTELEMETRY INC | $0 | – | -34,630 | -100.0% | -0.27% | – |
| IRWD | Exit | IRONWOOD PHARMACEUTICALS INC | $0 | – | -50,000 | -100.0% | -0.31% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -174,708 | -100.0% | -0.45% | – |
| OLED | Exit | UNIVERSAL DISPLAY CORP | $0 | – | -15,000 | -100.0% | -0.49% | – |
| RXDX | Exit | IGNYTA INC | $0 | – | -229,748 | -100.0% | -0.60% | – |
| SGY | Exit | STONE ENERGY CORPput | $0 | – | -108,100 | -100.0% | -0.63% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -140,969 | -100.0% | -0.64% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -747,748 | -100.0% | -0.80% | – |
| RTRX | Exit | RETROPHIN INC | $0 | – | -98,788 | -100.0% | -0.84% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -42,000 | -100.0% | -0.92% | – |
| CYNA | Exit | CYNAPSUS THERAPEUTICS INC | $0 | – | -115,400 | -100.0% | -0.93% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -8,500 | -100.0% | -0.94% | – |
| PACB | Exit | PACIFIC BIOSCIENCES CALIF IN | $0 | – | -300,000 | -100.0% | -1.01% | – |
| INSM | Exit | INSMED INC | $0 | – | -220,000 | -100.0% | -1.04% | – |
| PODD | Exit | INSULET CORP | $0 | – | -75,000 | -100.0% | -1.09% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -50,000 | -100.0% | -1.45% | – |
| RRM | Exit | RR MEDIA LTD | $0 | – | -611,818 | -100.0% | -3.84% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| IOVANCE BIOTHERAPEUTICS INC | 24 | Q1 2023 | 21.2% |
| IRIDEX CORP | 20 | Q3 2019 | 8.1% |
| ARROWHEAD PHARMACEUTICALS INC | 20 | Q2 2023 | 7.9% |
| IMMUNOMEDICS INC | 19 | Q3 2020 | 20.6% |
| VERACYTE INC | 19 | Q3 2019 | 10.1% |
| ASCENDIS PHARMA A S | 18 | Q2 2020 | 7.2% |
| XENON PHARMACEUTICALS INC | 18 | Q3 2022 | 4.6% |
| CAS MED SYS PAR $0.004 | 18 | Q1 2019 | 6.4% |
| APELLIS PHARMACEUTICALS INC | 17 | Q3 2023 | 18.4% |
| KURA ONCOLOGY INC. COMMON STOCK | 17 | Q3 2023 | 8.1% |
View ACUTA CAPITAL PARTNERS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| BCLS Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| Jiya Acquisition Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| VistaGen Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| Larimar Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
| CATALYST BIOSCIENCES, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Aadi Bioscience, Inc. | September 07, 2021 | 1,529,402 | 7.2% |
| Kadmon Holdings, Inc. | February 14, 2020 | 7,373,333 | 4.6% |
| IRIDEX CORPSold out | November 13, 2019 | 0 | 0.0% |
| ASSEMBLY BIOSCIENCES, INC. | February 14, 2019 | 718,500 | 2.8% |
| CAS MEDICAL SYSTEMS INC | February 14, 2019 | 5,263,508 | 18.2% |
View ACUTA CAPITAL PARTNERS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View ACUTA CAPITAL PARTNERS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.